Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection. - Wikidata - awgldk - TriplyDB

Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection.

Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection.

http://www.wikidata.org/entity/Q33844192

about

Hepatitis C Virus, Insulin Resistance, and Steatosis Hepatitis C genotype 4: The past, present, and future Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV Dietary sugar intake increases liver tumor incidence in female mice.The maternal womb: a novel target for cancer prevention in the era of the obesity pandemic?Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: a cross-sectional study.Insulin resistance and chronic liver disease.Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma.Effects of GLUT4 expression on insulin resistance in patients with advanced liver cirrhosis.Oncogenic potential of hepatitis C virus proteins Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma.The investigation of glucose metabolism and insulin secretion in subjects of chronic hepatitis B with cirrhosis Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial.GC Gene Polymorphism and Unbound Serum Retinol-Binding Protein 4 Are Related to the Risk of Insulin Resistance in Patients With Chronic Hepatitis C: A Prospective Cross-Sectional Study.Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy.Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver disease Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications.Use of HOMA-IR in hepatitis C.Insulin sensitizers for the treatment of non-alcoholic fatty liver disease Testosterone in men with advanced liver disease: abnormalities and implications.Optimal management of patients with chronic hepatitis C and comorbidities.Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma.Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions.Confluence of Epidemics of Hepatitis C, Diabetes, Obesity, and Chronic Kidney Disease in the United States Population.Assessment of serum adiponectin in Egyptian patients with HCV-related cirrhosis and hepatocellular carcinoma.Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end-stage liver disease score.Diabetes mellitus not an unfavorable factor on the prognosis of hepatitis C virus-related hepatocellular carcinoma.Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients.Adiponectin in chronic hepatitis C.Successful Hepatitis C Antiviral Therapy Induces Remission of Type 2 Diabetes: A Case Report.Low testosterone as a better predictor of mortality than sarcopenia in men with advanced liver disease.Exacerbation of insulin resistance and hepatic steatosis deriving from zinc deficiency in patients with HCV-related chronic liver disease.Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives Insulin resistance in non-diabetic patients of chronic Hepatitis C.Alterations of insulin-like growth factor I (IGF-I) and estradiol serum levels in chronic hepatitis C.Association of tyrosine with insulin resistance in hepatitis C virus-related chronic liver disease.

P2860

Q26751755-D6C64047-8EFE-4951-8908-B773F46A7852 Q26775815-5495DFDA-436D-44B3-A299-A99755F53B0F Q28079826-A5719C72-143C-49AA-806E-A8D24C93B8B1 Q30277250-8B3DBC5D-D978-4EC5-9589-12CBC568AE0F Q30404178-BFB4862E-B4C7-4729-8338-DD2D2A899037 Q34511085-4BBFA00B-E340-4940-9FCE-96CA959FC536 Q35054630-68BD7BB2-CCFF-419D-A0CD-BD8D7BC6E774 Q35073012-970109C1-8E6C-4122-941A-E028B4B5F9AF Q35107341-5BA6C8AF-0D00-44CD-8E1B-C4771B9FEEAD Q35148857-74F5D8B8-E8A6-4187-9CA8-8553AA449FB5 Q35261292-A8833F3D-8F8C-4C9B-A7B3-D476BCA659C2 Q35555547-85C5117D-ADC5-4D7F-89AE-2479B753C0EA Q36375476-823AC8FD-81EB-4D9A-9EA1-7DEC73F7CDF1 Q36379566-60D0058B-8E4E-4F10-AEB4-6FAABF937538 Q37113118-DC3678C1-17E9-41B8-A67B-7F20E9E70AC4 Q37207111-9D594D37-8A52-4DDE-9A98-AD727EA68F2B Q37328172-9436EB9F-FF27-4656-823C-4204A09C903B Q37356254-97BF330B-0CE0-4A59-857B-8B0CAB9B8ABB Q37527686-8E9746D8-CE27-473D-BD23-3B776C4405A5 Q37685491-26590205-4187-43D6-BD96-8B3277559063 Q37879191-769641CD-FA6F-446F-865A-8D6EA09A86BB Q37931383-01562365-B6F4-4393-8CA2-0031380CD501 Q38209666-D25C98B5-B178-432B-A73F-9738D5BC0573 Q38236451-D65EEF7A-07B1-4CC0-B837-B0552DBBFADC Q38295819-674C44B8-5F84-4A57-84AF-645F38997A7A Q38540380-CD36D29D-C074-4F8D-B591-71D1EA3A90CC Q38723591-722306D6-1CB2-451D-9400-7AE1AEB08D37 Q38745903-14D23120-B4C8-4B6A-9CF4-DC0DDDBB72FA Q39042825-F897280A-58F4-4BFB-B3EB-D492586EDAA1 Q39473080-EE6EA29B-6037-4BE0-B08A-382C89369A30 Q40308936-B0FF616D-5597-4850-8725-239944ADF1DF Q40445597-8736ED37-503E-4A68-B057-B05069957291 Q40729168-1D86FF2C-D2E5-4B4E-8C9C-AC2E2BA7694B Q40945393-24D52630-35F2-4A0C-BC05-43F26B16E2A4 Q41297040-2316D79E-AC61-44A7-96A2-0FFD9B89E053 Q41654021-797FC899-4885-4FD1-B927-503119F96977 Q41706847-792EEFCF-51AF-4D93-80D4-12B81FC68721 Q42024080-E38E245B-DCE8-4119-9BF3-A53294F90068 Q42150842-E83C8728-9166-4450-8124-3CE9525D08DD Q42279859-F85636D2-EB28-44E6-9B1A-087E63309BE4

P2860

Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection.

http://www.wikidata.org/entity/Q33844192

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Insulin resistance is associat ...... chronic hepatitis C infection.

@ast

Insulin resistance is associat ...... chronic hepatitis C infection.

@en

type

label

Insulin resistance is associat ...... chronic hepatitis C infection.

@ast

Insulin resistance is associat ...... chronic hepatitis C infection.

@en

prefLabel

Insulin resistance is associat ...... chronic hepatitis C infection.

@ast

Insulin resistance is associat ...... chronic hepatitis C infection.

@en

P1433

Q33844192-6732AD49-AB04-4ED5-ADF8-7CA0DA5FC380

P1476

Q33844192-1A9877AC-AB60-46A6-A9E4-E399D2CECB18

P2093

Q33844192-0F76F2E9-6D82-4292-8950-ECDC38228BF0

Q33844192-86A495E3-2FCD-495B-A2C0-74610A7DC465

Q33844192-894915AD-18EE-4665-AAC1-822F0CF65AA3

Q33844192-9EEB3927-5643-4D9C-9443-0EA107C1BA81

Q33844192-AFE56F17-CFC7-47B3-B530-3FC606E1B601

Q33844192-C3E916D9-A2DC-439F-AEA3-8EA7D4099B2E

Q33844192-EF1AF6D2-C15A-4238-A40B-B8C31B8AAD0E

Q33844192-F29C4FD6-8D19-4EC5-A96C-559B0988710C

Q33844192-FC0A607D-A405-4736-B8D5-FF06734DD2FA

Q33844192-FDA8D0C1-C813-4AD5-B130-E4F7DDE1EE5A

P2860

Q33844192-058B74A9-F81D-46A5-A6AA-567122952BE8

Q33844192-069A6917-8BFD-489F-9510-4096A98AA6ED

Q33844192-0CA27E99-760C-40E2-B88F-4D2897DCBE31

Q33844192-10C5C0CC-1F31-4978-BDB2-E119A536D0D1

Q33844192-1AAC115F-1A1A-4FD4-A6A3-E07A5B972B0C

Q33844192-1B507EBC-193E-48F2-ACEB-37B8DF58B4D8

Q33844192-22F22577-41CF-4FD7-B7F7-780E7A764A86

Q33844192-2A0169C5-195E-4A86-BFB7-48E1A29E5A00

Q33844192-33029CE6-4A66-455B-A8B4-D0205A6D6EDA

Q33844192-357B24E1-E293-439B-8805-D4BE20720D69

P304

Q33844192-A629C37E-A11E-49C5-ADFA-8D8BB7EBFEB9

P31

Q33844192-589625F1-FC08-45DF-96C9-BC14ECB4BB1B

P356

Q33844192-46685B17-4F1A-442A-9016-CB6816D0C049

P407

Q33844192-890B2D74-5CD0-47AC-A1DE-3D1EABAF4157

P433

Q33844192-F7D0F848-F3B2-41AF-9E48-EEFC9E28722B

P478

Q33844192-E7CA98FE-E132-439D-9509-9733CBDA6FD3

P577

Q33844192-15DEDE11-40CB-4F5C-98A7-0C0793415640

P5875

Q33844192-18A0D1CC-7938-403B-9FB9-996C9CEF7C3C

P698

Q33844192-B0AB815B-6960-4119-BDDE-AFDB284B8505

P921

Q33844192-7C7344EF-6C68-46D5-964B-960E6E73EB66

P932

Q33844192-FE484043-DAB3-4BA7-B5D0-F8FF5B7634A9

P356

WJG.V16.I18.2265

P1433

World Journal of Gastroenterology

P1476

Insulin resistance is associat ...... chronic hepatitis C infection.

@en

P2093

Chao-Hung Hung

http://www.w3.org/2001/XMLSchema#string

Chien-Hung Chen

http://www.w3.org/2001/XMLSchema#string

Chuan-Mo Lee

http://www.w3.org/2001/XMLSchema#string

Jing-Houng Wang

http://www.w3.org/2001/XMLSchema#string

Kuo-Chin Chang

http://www.w3.org/2001/XMLSchema#string

Ming-Chao Tsai

http://www.w3.org/2001/XMLSchema#string

Sheng-Nan Lu

http://www.w3.org/2001/XMLSchema#string

Tsung-Hui Hu

http://www.w3.org/2001/XMLSchema#string

Yi-Hao Yen

http://www.w3.org/2001/XMLSchema#string

Yuan-Hung Kuo

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C virus infection

Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

Management of hepatocellular carcinoma

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece.

Adiponectin and breast cancer risk.

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study.

An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.

Adipocytokines and cancer.

P304

2265-2271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V16.I18.2265

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44588555

http://www.w3.org/2001/XMLSchema#string

P698

20458764

http://www.w3.org/2001/XMLSchema#string

P921

P932

2868220

http://www.w3.org/2001/XMLSchema#string